[ad_1]
Asthma is a chronic inflammatory lung disease which affects people across all ages. It creates inflammation inside the walls of airways, causing airways to narrow, swell and produce extra mucous. It is caused by genetic factors or environmental triggers, or a combination of both. Some of the symptoms of asthma are: Coughing, wheezing, trouble in breathing and tightness or pain in the chest.
Asthma is triggered by exposure to various air-borne allergens such as dust mites in carpets, bedding and furniture, pet dander, pollens, and mold, cold air, physical exertion, respiratory infection, air pollutants, and certain medications. Asthma is diagnosed via a physical examination and test that measures lung function. Moreover, other tests such as imaging tests, allergy testing, nitric oxide testing, sputum eosinophils testing, and provocation testing for exercise and cold-induced asthma are used for diagnosing diseases.
Prevention and long-term control are essential steps to control asthma attacks. Inhaled corticosteroids, combination inhalers, long-acting beta agonists, theophylline, and leukotriene modifiers are some of the long-term asthma control medications. Asthma is treated with the help of such devices as nebulizers, inhalers and respirators.
Request Sample Report @ https://www.persistencemarketresearch.com/samples/4758
A nebulizer is a drug delivery device that converts liquid into aerosol droplets for inhalation. It is used to administer medication in the lungs in the form of vapors so as to relieve bronchospam, and dyspnea.
Inhalers, on the other hand, are devices that deliver drugs directly to the airways. Aerosol inhalers and dry powder inhalers are the two types used for the treatment of asthma. Likewise, respirators are devices that protect the wearer from inhaling harmful dust, fumes and gases.
North America dominates the global market for nebulizers, inhalers and respirators for asthma treatment in the region. Asia Pacific is expected to show growth in the global nebulizers, inhalers and respirators for asthma treatment market, with China and India being the fastest-growing markets in the Asia Pacific region. The key driving forces for the nebulizers, inhalers and respirators for asthma treatment market: A large pool of patients, increasing disposable income, higher environmental pollution, a rising in the number of smokers, increasing healthcare awareness, expansion of the aging population base, increasing healthcare expenditure, and improving healthcare infrastructure in the region.
The growth of the global nebulizers, inhalers and respirators for asthma treatment market, on the other hand, is hinged on: Rising prevalence of asthma, increasing prevalence of obesity, spike in pollution levels, and increasing health expenditure. In addition, an uptick in the number of smokers, greater disposable income, increased awareness of the benefits of asthma, and a growing demand for growth of nebulizers, inhalers and respirators for asthma treatment market. However, the high cost of asthma treatment acts as a major restraint for the growth of global nebulizers, inhalers and respirators for asthma treatment market.
Request Report TOC @ https://www.persistencemarketresearch.com/methodology/4758
Key segments covered in this report are:
Top companies profiled in this report are:
- 3M Healthcare
- Astrazeneca
- GlaxoSmithKline, Inc.
- Philips Respironics
- Omron
- Invacare
- Boehringer Ingelheim
- Drager.
Source link
